Results 11 to 20 of about 19,922 (207)

Duloxetine: A Review of its Safety and Efficacy in the Management of Fibromyalgia Syndrome

Journal of Central Nervous System Disease, 2010
Fibromyalgia (FM) is a chronic disorder characterized by widespread pain and other associated symptoms including fatigue, insomnia, cognitive/memory problems, and even psychological distress. Duloxetine is one of three FDA approved medications (the other
Howard S. Smith, Donna Bracken, Joshua M. Smith   +2 more
doaj   +2 more sources

Duloxetine for the management of fibromyalgia syndrome

Journal of Pain Research, 2009
Beth A Scholz, Cara L Hammonds, Chad S BoomershineDepartment of Medicine, Vanderbilt University, Nashville, TN, USAAbstract: Fibromyalgia syndrome (FMS) is a widespread pain condition associated with a wide range of additional symptoms including fatigue,
Beth A Scholz, Cara L Hammonds, Chad S Boomershine   +2 more
doaj   +1 more source

Duloxetine in the management of diabetic peripheral neuropathic pain

Patient Preference and Adherence, 2011
Michelle J Ormseth, Beth A Sholz, Chad S BoomershineDivision of Rheumatology and Immunology, Vanderbilt University, Nashville, TN, USAAbstract: Diabetic neuropathy affects up to 70% of diabetics, and diabetic peripheral neuropathic pain (DPNP) is the ...
Boomershine CS, Scholz BA, Ormseth MJ
doaj   +1 more source

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. [PDF]

PLoS ONE, 2012
This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects.
Cédric M Hysek, Linda D Simmler, Valentina G Nicola, Nerina Vischer, Massimiliano Donzelli, Stephan Krähenbühl, Eric Grouzmann, Jörg Huwyler, Marius C Hoener, Matthias E Liechti   +9 more
doaj   +4 more sources

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports

Drug, Healthcare and Patient Safety, 2013
David G Perahia,1 Mark E Bangs,2 Qi Zhang,2 Yingkai Cheng,2 Jonna Ahl,2 Elijah P Frakes,2 Michael J Adams,2 James M Martinez2 1Neurosciences, Lilly Research Centre, Windlesham, Surrey, UK; 2Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA ...
Perahia DG, Bangs ME, Zhang Q, Cheng Y, Ahl J, Frakes EP, Adams MJ, Martinez JM   +7 more
doaj   +1 more source

Visual hallucination induced by duloxetine use: a male case diagnosed with generalized anxiety disorder

Psychiatry and Clinical Psychopharmacology, 2018
Duloxetine is a serotonin-noradrenaline reuptake inhibitor. It has been increasingly used in child and adolescent psychiatric practice in recent years. In this paper, we presented a 16-year-old male patient diagnosed with generalized anxiety disorder who
Kemal Utku Yazici, Ipek Percinel Yazici
doaj   +2 more sources

Duloxetine-Induced Sleep Bruxism and Tooth Fracture in Fibromyalgia [PDF]

Düzce Tıp Fakültesi Dergisi
Duloxetine is a serotonin-norepinephrine reuptake inhibitor that is approved for the treatment of fibromyalgia. Duloxetine has many side effects such as nausea, somnolence, insomnia, decreased appetite, dry mouth, and constipation.
İsmail Tunçekin, Murat Toprak
doaj   +2 more sources

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine

Diabetes, Metabolic Syndrome and Obesity, 2010
Lindsay Zilliox1, James W Russell1,21Department of Neurology, Neuromuscular Division, The University of Maryland School of Medicine, 2VA Maryland Health Care System, Baltimore, MD, USAIntroduction: Neuropathy is one of the most frequent ...
Russell J, Zilliox L
doaj   +3 more sources

Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies

Journal of Pain Research, 2017
Hiroyuki Enomoto,1 Shinji Fujikoshi,2 Jumpei Funai,3 Nao Sasaki,4 Michael H Ossipov,5 Toshinaga Tsuji,6 Levent Alev,7 Takahiro Ushida8 1Medical Science, Eli Lilly Japan K.K., Tokyo, 2Statistical Science, 3Science Communications, 4Medical Science, Eli ...
Enomoto H, Fujikoshi S, Funai J, Sasaki N, Ossipov MH, Tsuji T, Alev L, Ushida T   +7 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source